๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mass spectrometric analysis of innovator, counterfeit, and follow-on recombinant human growth hormone

โœ Scribed by Haitao Jiang; Shiaw-Lin Wu; Barry L. Karger; William S. Hancock


Publisher
American Institute of Chemical Engineers
Year
2009
Tongue
English
Weight
270 KB
Volume
25
Category
Article
ISSN
8756-7938

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

We have performed a detailed characterization of recombinant human growth hormone that included the identification of the entire sequence with disulfide linkages as well as subtle modifications by a sensitive liquid chromatography coupled online with tandem mass spectrometry (LCโ€MS) approach using the accurate peptide mass (FTICR MS) and sequence assignment (MS/MS measurement). The extent of oxidation, deamidation, and chain cleavages were measured by the ratio of peak areas of the nonmodified peptide vs. the sum of peak area of the nonmodified and modified peptides in the same LCโ€MS analysis. The subtle but distinct differences were found in the recombinant human growth from the three manufacturers (the followโ€on, counterfeit, and the original innovator products). In relative comparison, the followโ€on product had the highest degree of oxidation at methionine residues, followed by the counterfeit product, and the original innovator product had the least amount of oxidation at all three sites with the similar oxidation order. In cases, the oxidation order was Met14 > Met125 > Met170. In contrast, the followโ€on had the least amount of deamidation at aspargine (Asn149), and the counterfeit had the highest degree of deamidation at this site. For the chain cleavage, the followโ€on product had the highest cleavage occurring at T 10 peptide (between Asn99 and Ser100), the counterfeit had the highest cleavage on T4 peptide, (between Glu30 and Phe31), and the original innovator product with the least amount of cleavages on both sites. These subtle but distinct differences are likely because of nonidentical manufacturing, formulation procedures, and storage conditions. ยฉ 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009


๐Ÿ“œ SIMILAR VOLUMES


Influence of scale-up on the quality of
โœ F. Bylund; A. Castan; R. Mikkola; A. Veide; G. Larsson ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 232 KB ๐Ÿ‘ 2 views

The aerobic fed-batch production of recombinant human growth hormone (rhGH) by Escherichia coli was studied. The goal was to determine the production and protein degradation pattern of this product during fed-batch cultivation and to what extent scale differences depend on the presence of a fed-batc

Effect of zinc binding and precipitation
โœ Tzung-Horng Yang; Jeffrey L. Cleland; Xanthe Lam; Jeffrey D. Meyer; Latoya S. Jo ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 254 KB ๐Ÿ‘ 2 views

Metal-induced precipitation of protein therapeutics is being used and further developed as a processing step in protein formulation and may have utility in protein purification and bulk storage. In such processes, it is imperative that native protein structure is maintained and the metal complexatio